Clinical Trial

Research on the Improvement of Intestinal and Immune Functions by Probiotics

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Evaluate the effectiveness and safety of Limosilactobacillus fermentum LF61 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Trial Details
NCT Number NCT06873425
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Intestinal Health
Enrollment 40 participants
Start Date 2025-03-10
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-12